English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Inflammatory bowel disease (IBD) refers to a group of chronic non-specific inflammatory conditions of the gastrointestinal tract, and is particularly represented by ulcerative colitis (UC) and Crohn’s disease (CD). In recent years, the incidence of IBD appears to remain stable in the Western hemisphere, but in China, it shows a rapidly growing trend due to the rapid industrialization, urbanization and westernized lifestyle. An epidemiological survey by Peking Union Medical College Hospital in Daqing, China showed that the incidence of UC is 1.64 per 1 and for CD, it is 0.13 per 1.[1] Although the absolute incidence of IBD is not currently disturbing, the great number of patients with IBD in this country has added up to a concerning burden, because the disease is usually liable to relapse, hardly curable, and may last a long course. Based on the characteristics and the increasing incidence of IBD, it is estimated that in the near future, IBD will become a common gastrointestinal disorder in China.

journal of translational internal medicine

Endoscopic diagnosis and treatment of precancerous colorectal lesions in patients with inflammatory bowel disease: How does the latest SCENIC international consensus intersect with our clinical practice?